CEFEPIME FOR INJECTION USP

Google image searchProduct monograph

Active ingredient

cefepime (cefepime hydrochloride), 2 G/VIAL

DIN: 02499096

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIALS

Schedule: Prescription

Company: HIKMA CANADA LIMITED

Date: 25-MAY-2022

ATC:

Reference brand drug: Maxipime

Pharmaceutical standard: USP

Search on Google